www.fdanews.com/articles/130553-novartis-sells-us-rights-to-enablex-for-400-million

Novartis Sells US Rights to Enablex for $400 Million

September 24, 2010

Novartis agreed to sell the U.S. rights to bladder medicine Enablex for $400 million.
DailyFinance